GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » U-Neuron Biomedical Inc (ROCO:6973) » Definitions » Short-Term Capital Lease Obligation

U-Neuron Biomedical (ROCO:6973) Short-Term Capital Lease Obligation : NT$4.77 Mil (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is U-Neuron Biomedical Short-Term Capital Lease Obligation?

U-Neuron Biomedical's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was NT$4.77 Mil.

U-Neuron Biomedical's quarterly Short-Term Capital Lease Obligation declined from Dec. 2022 (NT$4.40 Mil) to Jun. 2023 (NT$2.20 Mil) but then increased from Jun. 2023 (NT$2.20 Mil) to Dec. 2023 (NT$4.77 Mil).

U-Neuron Biomedical's annual Short-Term Capital Lease Obligation increased from Dec. 2021 (NT$0.00 Mil) to Dec. 2022 (NT$4.40 Mil) and increased from Dec. 2022 (NT$4.40 Mil) to Dec. 2023 (NT$4.77 Mil).


U-Neuron Biomedical Short-Term Capital Lease Obligation Historical Data

The historical data trend for U-Neuron Biomedical's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

U-Neuron Biomedical Short-Term Capital Lease Obligation Chart

U-Neuron Biomedical Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Short-Term Capital Lease Obligation
- - 4.40 4.77

U-Neuron Biomedical Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Short-Term Capital Lease Obligation - - 4.40 2.20 4.77

U-Neuron Biomedical Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.


U-Neuron Biomedical Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of U-Neuron Biomedical's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


U-Neuron Biomedical (ROCO:6973) Business Description

Industry
Comparable Companies
Traded in Other Exchanges
N/A
Address
U-Neuron Biomedical Inc is engaged in research and development of stem cell storage & separation technology, and treatment application technology. It has patent on the Technology of Culture and Isolation of Amniotic Fluid Stem Cell.

U-Neuron Biomedical (ROCO:6973) Headlines

No Headlines